Modern medicine stands at the threshold of a computational renaissance, where biological complexity meets algorithmic sophistication to unlock unprecedented therapeutic possibilities. As healthcare systems confront rising costs and limited treatment options for complex diseases, generative AI in pharma emerges as the cornerstone of a new therapeutic paradigm, fundamentally altering our...

Rare diseases affect millions of individuals worldwide, yet the complexity of researching these conditions makes global trials both essential and ethically challenging. With small, dispersed patient populations, high stakes for treatment, and diverse regulatory environments, rare disease trials require ethical rigor at every stage. Upholding integrity and fairness is not...